Table:
begin	end	state
1	6	cytoplasmic
7	25	transmembrane
26	27	cytoplasmic
28	29	non-cytoplasmic
30	53	transmembrane
54	62	cytoplasmic
63	64	non-cytoplasmic
65	80	transmembrane
81	104	non-cytoplasmic
105	131	transmembrane
132	142	cytoplasmic
143	161	transmembrane
162	180	non-cytoplasmic
181	204	transmembrane
205	246	cytoplasmic
247	267	transmembrane
268	288	non-cytoplasmic
289	308	transmembrane
309	319	cytoplasmic
320	338	transmembrane
339	351	non-cytoplasmic
352	372	transmembrane
373	378	cytoplasmic
379	399	transmembrane
400	404	non-cytoplasmic
405	428	transmembrane
429	439	cytoplasmic
440	464	transmembrane
465	465	non-cytoplasmic

Input:
>BPHYT_RS16725
MEAVHGSTLLVFAVIAIALLILLITRYKVYPFLVLIIVSLLLGLASGMPMATIVKSFETG
NGNTLGHIAIVVGLGTMLGKMMAESGGAERIATTLIDFFGEKNIHWAMMIVAIIVGLPVF
FEVGFVLLIPIAFNVAKRTNKSLLLVGLPMVAGLSVVHGLLPPHPAAMLAVQAYHADIGR
TIAYGLIVGVPTAIVAGPLFALMISRYIKLPKENALAAQFLGHGDETKNGAQTAAQNVAP
KRELPSFGITLLTILLPVILMLVGSWADLFTTPKTLPNDLLHFAGNSDVALLIAVLVSFW
TFGASRGFTREQIQKFCGDCLAPIAGITLIVGAGGGFGRVLMDSGISKEIVNVATAMHLS
PLLFGWLVAALIRLATGSATVAMTTACGIVAPIASASGVHVEPELLVLATGSGSLIFSHV
NDGGFWLIKEYFGMTVGQTFKTWSLLETIISLMGLGLTFALAAVV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server